Company profile
UK company 13517470, incorporated on 19 July 2021.
ExpressionEdits
Redefining the status quo of protein expression with direct impact on recombinant protein yields and the quality and efficacy of DNA medicines.
Company number 13517470
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last accounts made up date
Last confirmation statement made up date
AD01 | Transaction MzM1MTQzNTc1MGFkaXF6a2N4
Published 28 Jul 2026 10:12
Company registered at Companies House
ExpressionEdits develops a platform for transgene and genetic production.
The company intends to commercialise the discovery of the importance of introns in transgenes.
The company started operations mid 2022. It has established a small team of wet-lab (3) and bioinformatics personnel (3) who are building a pipeline that is designed to improve gene expression in mammalian cells.
None yet, still in start-up phase
